Optic Atrophy
📧 Sign up to get email alerts when something new happens for Optic Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
This update describes an international registry and clinical study for Wolfram syndrome and WFS1-related disorders, which is currently recru…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study
A prospective, multi-center observational trial evaluating optic nerve head blood flow using multimodal imaging in neuro-ophthalmic conditio…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Stem Cell Ophthalmology Treatment Study II [NA]
The clinical trial update indicates that the Stem Cell Ophthalmology Treatment Study II is currently recruiting for multiple retinal and opt…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
Status update on a natural history study of Autosomal Dominant Optic Atrophy due to OPA1 mutation; the trial is terminated.
-
CLINICAL_TRIALS research · 2016-08-29Clinical Trial Update: Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating deferiprone together with incretin-based therapy for Wolfram syndrome type 2, with attention to rel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-09-17Clinical Trial Update: Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating autologous bone marrow–derived cells for optic nerve disease (optic atrophy) sponsored by Cha…